Agios Files FDA Application Seeking Accelerated Approval Of Mitapivat For Sickle Cell Disease
12/5 17:01
(RTTNews) - Rare disease drugmaker Agios Pharmaceuticals Inc. (AGIO) on Tuesday announced the submission of a supplemental New Drug Application, or sNDA, to the U.S. Food and Drug Administration seeking accelerated approval of mitapivat for the treatment of sickle cell disease....